Icon PLC (ICLR): Operating Cash Flow
$1.04B
Year ended 2025-12-31
+22.5%
3-year compound annual growth
+12.8%
5-year compound annual growth
+14.0%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.04B | -19.5% | 2026-05-27, From 2025-01-01 |
| 2024-12-31 | $1.29B | +10.8% | 2026-05-27, From 2024-01-01 |
| 2023-12-31 | $1.16B | +106.1% | 2026-05-27, From 2023-01-01 |
| 2022-12-31 | $563.32M | -32.1% | 2025-02-21, From 2022-01-01 |
| 2021-12-31 | $829.14M | +46.0% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $568.03M | +37.7% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $412.54M | +53.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $268.64M | -29.9% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $383.08M | +47.8% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $259.20M | -7.1% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $279.07M | +64.2% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $169.95M | -23.2% | 2015-03-12, From 2014-01-01 |
| 2013-12-31 | $221.23M | +95.0% | 2015-03-12, From 2013-01-01 |
| 2012-12-31 | $113.43M | +461.8% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $20.19M | -76.9% | 2014-03-12, From 2011-01-01 |
| 2010-12-31 | $87.43M | -65.7% | 2013-03-06, From 2010-01-01 |
| 2009-12-31 | $255.07M | +213.8% | 2012-03-02, From 2009-01-01 |
| 2008-12-31 | $81.28M | n/a | 2011-03-22, From 2008-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Icon PLC (ICLR) | 2025-12-31 | $1.04B | -19.5% |
| Incyte Corp (INCY) | 2025-12-31 | $1.41B | +321.5% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $2.65B | -2.3% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $737.65M | +0.4% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $713.22M | +17.1% |
| NRC Health (NRC) | 2025-12-31 | $26.45M | -23.6% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$34.41M | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$36.45M | n/m |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | -$3.87M | n/m |
Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗